Hypertrophic Cardiomyopathy: Understanding Causes, Symptoms, and Advanced Care
Comprehensive overview of hypertrophic cardiomyopathy including diagnosis, symptoms, treatment, and innovative care options.
What Is Hypertrophic Cardiomyopathy?
Hypertrophic cardiomyopathy (HCM) is a disease characterized by abnormal thickening of the heart muscle, particularly the walls of the left ventricle, which can interfere with the heart’s ability to pump blood effectively. This thickening often occurs in the interventricular septum, the muscle wall separating the left and right ventricles, and may obstruct blood flow out of the heart.
HCM is primarily a genetic disorder caused by mutations in genes encoding sarcomeric proteins responsible for muscular contraction. These genetic changes lead to excessive growth and stiffness of the heart muscle, resulting in varied clinical presentations and symptoms.
Causes and Genetics of Hypertrophic Cardiomyopathy
The underlying cause of HCM lies in mutations affecting one or more of over a dozen sarcomeric genes. These mutations alter the structure and function of the contractile heart muscle proteins, leading to hypercontractility and hypertrophy. HCM’s inheritance follows an autosomal dominant pattern, meaning a child of an affected parent has a 50% chance of inheriting the condition.
Not everyone with the gene mutation develops hypertrophy immediately; some may carry the mutation without showing symptoms or detectable muscle thickening, a state referred to as genotype positive, phenotype negative.
Symptoms and Complications
People with HCM may experience a wide range of symptoms and complications, from being completely asymptomatic to suffering from severe heart dysfunction. Common symptoms include:
- Chest pain or discomfort, often triggered by exertion
- Shortness of breath, especially during physical activity or when lying flat
- Fatigue and reduced exercise tolerance
- Palpitations caused by arrhythmias (abnormal heart rhythms)
- Lightheadedness, dizziness, or fainting (syncope), sometimes due to obstruction or arrhythmias
HCM can lead to significant complications such as:
- Outflow tract obstruction: The thickened muscle partly blocks blood flow out of the heart, causing increased pressure and symptoms.
- Arrhythmias: Including atrial fibrillation and potentially life-threatening ventricular arrhythmias that increase the risk for sudden cardiac death.
- Heart failure: Due to impaired filling and stiffness of the ventricles.
- Stroke: Especially in those with atrial fibrillation, due to blood clots forming in the heart.
Diagnosis of Hypertrophic Cardiomyopathy
Diagnosing HCM involves a combination of clinical evaluation, family history, and advanced cardiac imaging.
Physical Exam and History
Doctors may detect a heart murmur or abnormal heart sounds associated with obstruction or valve movement. Family history of sudden cardiac death or cardiomyopathy is a critical factor.
Electrocardiogram (ECG)
ECG may show signs of left ventricular hypertrophy or abnormal heart rhythms.
Imaging Tests
- Echocardiography (Echo): The primary test for visualizing the thickness of the heart muscle, evaluating outflow obstruction, and assessing heart function.
- Cardiac MRI: Provides detailed images and is useful when echocardiography is inconclusive, assessing scarring or fibrosis.
- Exercise stress testing: Measures functional capacity, evaluates symptoms during exertion, and identifies latent obstruction and arrhythmias.
Genetic Testing
Testing can identify mutations in sarcomeric genes and is useful for family screening and guiding management.
Treatment and Management
There is no cure for HCM, but multiple treatment strategies aim to relieve symptoms, prevent complications, and improve quality of life.
Medications
Medications aim to reduce the heart’s contractility and obstruction and control arrhythmias. Commonly used drugs include:
- Beta blockers: Slow heart rate and reduce contractility, improving filling and symptoms.
- Calcium channel blockers: Also reduce contractility and relieve obstruction.
- Disopyramide: A specialized drug used to decrease muscle contraction in obstructive cases, often combined with other medications.
Procedural Interventions
For patients with significant obstruction and symptoms refractory to medication, invasive procedures are options:
- Surgical myectomy: Removal of part of the thickened septum to relieve outflow obstruction. It has a high success rate and is considered the gold standard in specialized centers.
- Alcohol septal ablation: A less invasive catheter-based procedure that induces a controlled myocardial infarction in part of the septum to reduce thickness and obstruction.
Implantable Devices
To prevent sudden cardiac death from arrhythmias, certain high-risk patients may receive an implantable cardioverter-defibrillator (ICD) that monitors the heart rhythm and delivers shocks to terminate dangerous arrhythmias.
Management of Arrhythmias and Stroke Prevention
- Antiarrhythmic medications: Used to control atrial fibrillation and ventricular arrhythmias.
- Blood thinners: Recommended for patients with atrial fibrillation to reduce stroke risk.
- Pacemakers: May be implanted for controlling heart rates in certain rhythm disturbances.
Living with Hypertrophic Cardiomyopathy
Patients with HCM can lead active lives with appropriate management, but they should take precautions, including:
- Avoiding intense competitive sports or vigorous exercise that may trigger arrhythmias or sudden cardiac events.
- Maintaining hydration to prevent dehydration, which can worsen obstruction symptoms.
- Regular follow-up with cardiologists experienced in HCM to monitor disease progression, symptoms, and adjust treatment.
- Family screening and genetic counseling for relatives at risk.
Frequently Asked Questions (FAQs)
Q: Is hypertrophic cardiomyopathy inherited?
A: Yes, HCM mainly results from inherited mutations in sarcomeric genes, most commonly passed in an autosomal dominant pattern.
Q: Can hypertrophic cardiomyopathy cause sudden death?
A: Although many people with HCM live normal lives, it can cause sudden cardiac death, especially in young athletes, due to arrhythmias. Risk assessment and ICD implants help prevent this.
Q: What lifestyle changes can help manage HCM?
A: Avoiding strenuous exercise, staying hydrated, and regular medical evaluations are important steps in managing HCM symptoms and reducing risks.
Q: How is HCM diagnosed?
A: Diagnosis usually involves echocardiography and possibly cardiac MRI to detect heart muscle thickening, along with ECG, family history, and sometimes genetic testing.
Q: Are there treatments that can cure HCM?
A: Currently, there is no cure for HCM, but treatments like medications, surgical myectomy, alcohol septal ablation, and ICD implantation effectively manage symptoms and reduce risk.
References
- Hypertrophic Cardiomyopathy – MedlinePlus Medical Encyclopedia — U.S. National Library of Medicine. 2023-08-15. https://medlineplus.gov/ency/article/000192.htm
- Hypertrophic Cardiomyopathy: A Review — PubMed, NIH. 2015-03-01. https://pubmed.ncbi.nlm.nih.gov/25657602/
- Johns Hopkins Hypertrophic Cardiomyopathy Center Overview — Johns Hopkins Medicine. 2025-01-10. https://www.4hcm.org/coe/hopkins
- Understanding Hypertrophic Cardiomyopathy Webinar Series — Johns Hopkins Medicine, 2021-12-13 and 2022-01-14. https://www.youtube.com/watch?v=BmhDPDCxn3A, https://www.youtube.com/watch?v=0dJaiQWDL2Y
Similar Articles
Read full bio of medha deb
